Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer-Reference-Cited by-同舟云学术

Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer

Published:2019-09 Issue:5 Volume:57 Page:451-459
ISSN:2212-5345
Container-title:Respiratory Investigation
language:en
Short-container-title:Respiratory Investigation

Author:

Nakanishi Yu,Masuda Takeshi,Yamaguchi Kakuhiro,Sakamoto Shinjiro,Horimasu Yasushi,Nakashima Taku,Miyamoto Shintaro,Tsutani Yasuhiro,Iwamoto Hiroshi,Fujitaka Kazunori,Miyata Yoshihiro,Hamada Hironobu,Okada Morihito,Hattori Noboru

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference24 articles.

1. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012

2. Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer;Borghaei;N Engl J Med,2015

3. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer;Reck;N Engl J Med,2016

4. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer;Brahmer;N Eng J Med,2015

5. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of preexisting interstitial lung disease on outcomes of lung cancer surgery: A monocentric retrospective study;Respiratory Medicine and Research;2024-11

2. Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities;Cancer Immunology, Immunotherapy;2024-09-05

3. Update on Pulmonary Fibrosis;Advances in Clinical Radiology;2024-09

4. 18F-FDG-PET/CT Uptake by Noncancerous Lung as a Predictor of Interstitial Lung Disease Induced by Immune Checkpoint Inhibitors;Academic Radiology;2024-09

5. Lung Cancer and Interstitial Lung Diseases;Cancers;2024-08-13